Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.9702
+0.0467 (5.06%)
At close: Jun 25, 2025, 4:00 PM
0.9300
-0.0402 (-4.14%)
After-hours: Jun 25, 2025, 7:33 PM EDT
Opus Genetics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Opus Genetics stock have a consensus rating of "Strong Buy" and an average price target of $6.33, which forecasts a 552.44% increase in the stock price over the next year. The lowest target is $5 and the highest is $8.
Price Target: $6.33 (+552.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Opus Genetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +415.36% | Jun 17, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +518.43% | Apr 11, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +724.57% | Apr 1, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +724.57% | Feb 19, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +724.57% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
16.64M
from 10.99M
Increased by 51.41%
Revenue Next Year
28.10M
from 16.64M
Increased by 68.84%
EPS This Year
-0.86
from -2.15
EPS Next Year
-0.54
from -0.86
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 18.3M | 31.5M | 45.1M | ||
Avg | 16.6M | 28.1M | 25.7M | ||
Low | 15.4M | 25.0M | 9.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 66.2% | 89.3% | 60.3% | ||
Avg | 51.4% | 68.8% | -8.7% | ||
Low | 39.7% | 49.9% | -65.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.81 | -0.46 | -0.40 | ||
Avg | -0.86 | -0.54 | -0.58 | ||
Low | -0.97 | -0.70 | -0.76 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.